Cargando…

Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review

Implementing the most suitable treatment strategies and making appropriate clinical decisions about individuals with a first episode of psychosis (FEP) is a complex and crucial task, with relevant impact in illness outcome. Treatment approaches in the early stages should go beyond choosing the right...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crespo-Facorro, Benedicto, Pelayo-Teran, Jose Maria, Mayoral-van Son, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130917/ https://www.ncbi.nlm.nih.gov/pubmed/27553839 http://dx.doi.org/10.1007/s40120-016-0050-8

Ejemplares similares

S124. RECOVERY TRAJECTORIES IN FIRST EPISODE PSYCHOSIS PATIENTS: THE ROLE OF TIMING
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

S125. THE DYNAMIC RELATIONSHIP BETWEEN INSIGHT AND SUICIDAL BEHAVIOUR IN FIRST EPISODE PSYCHOSIS PATIENTS OVER 3-YEAR FOLLOW-UP
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial
por: Garrido-Sánchez, Lucía, et al.
Publicado: (2022)

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program
por: Pardo-de-Santayana, Guillermo, et al.
Publicado: (2020)

The right occipital lobe and poor insight in first-episode psychosis
por: Tordesillas-Gutierrez, Diana, et al.
Publicado: (2018)

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review
por: Gallardo-Ruiz, Ruth, et al.
Publicado: (2019)

Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2018)

Understanding sex differences in long-term outcomes after a first episode of psychosis
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2020)

S153. WHERE IS THE ABNORMAL BRAIN ACTIVITY IN FIRST EPISODE PSYCHOSIS?
por: Pau, Soldevila-Matias, et al.
Publicado: (2018)

Are we getting any better at staying better? The long view on relapse and recovery in first episode nonaffective psychosis and schizophrenia
por: Taylor, Mark, et al.
Publicado: (2019)

First episode psychosis and weight gain a longitudinal perspective in Cheshire UK: a comparison between individuals with nonaffective versus affective psychosis
por: Heald, Adrian H., et al.
Publicado: (2023)

T72. VERBAL MEMORY AND VOXEL BASED MORPHOMETRY IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS: A PROCESS ORIENTED APPROACH
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

F124. SEX DIFFERENCES IN OUTCOME IN FIRST EPISODE PSYCHOSIS PATIENTS: A 10-YEAR FOLLOW-UP STUDY
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2018)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

F245. COGNITIVE RESERVE DIFFERENCE IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS
por: Amoretti, Silvia, et al.
Publicado: (2018)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2019)

Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study
por: Juncal-Ruiz, Maria, et al.
Publicado: (2020)

Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2020)

Neuroanatomical Differences between First-Episode Psychosis Patients with and without Neurocognitive Deficit: A 3-Year Longitudinal Study
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2013)

F81. AGE OF ONSET OF CANNABIS USE AND COGNITIVE FUNCTION IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS PATIENTS: 3-YEAR FOLLOW-UP OUTCOME
por: Setién-Suero, Esther, et al.
Publicado: (2018)

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2014)

S173. GREY MATTER VOLUME DEFFICITS IN PATIENTS WITH A FIRST EPISODE NON-AFFECTIVE PSYCHOSIS AND SUICIDE RELATED BEHAVIOUR
por: Tordesillas-Gutiérrez, Diana, et al.
Publicado: (2018)

F145. WHAT ARE THE MAIN BRAIN CHANGES IN FMRI AFTER TREATMENT IN FIRST EPISODE PSYCHOSIS? A SYSTEMATIC REVIEW
por: Gonzalez, Carlos, et al.
Publicado: (2018)

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis
por: Muntané, Gerard, et al.
Publicado: (2023)

S101. DIFFERENTIATING NON-AFFECTIVE ACUTE REMITTING PSYCHOSIS (NARP) FROM SCHIZOPHRENIA IN FIRST-EPISODE PSYCHOSIS: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

T175. A 10-YEAR LONGITUDINAL STUDY OF GREY MATTER VOLUME IN FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS
por: Tordesillas-Gutiérrez, Diana, et al.
Publicado: (2018)

Assessment of the Role of IQ in Associations Between Population Density and Deprivation and Nonaffective Psychosis
por: Lewis, Gemma, et al.
Publicado: (2020)

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences
por: Setién-Suero, Esther, et al.
Publicado: (2017)

The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals
por: Juncal-Ruiz, María, et al.
Publicado: (2018)

T67. TRAUMA IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS: ASSOCIATIONS AND DISSOCIATIONS WITH COGNITIVE FUNCTIONING IN CHILDHOOD AND ADULTHOOD
por: Mollon, Josephine, et al.
Publicado: (2020)

O6.7. COMMON NEUROANATOMICAL ABNORMALITIES IN FIRST EPISODE PSYCHOSIS ACROSS SEVERAL INDEPENDENT SAMPLES
por: Vieira, Sandra, et al.
Publicado: (2018)

Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-up Study
por: Ayesa-Arriola, Rosa, et al.
Publicado: (2016)

Biomarkers as Proxies for Cognitive Reserve: the role of high density lipoprotein cholesterol in first episode of psychosis
por: Magdaleno Herrero, R., et al.
Publicado: (2023)

Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
por: Vázquez-Bourgon, J., et al.
Publicado: (2022)

Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence
por: Vieira, Sandra, et al.
Publicado: (2020)

Dimensions of Hallucinations and Delusions in Affective and Nonaffective Illnesses
por: Kumari, Ranju, et al.
Publicado: (2013)

Association of Residential Mobility Over the Life Course With Nonaffective Psychosis in 1.4 Million Young People in Sweden
por: Price, Ceri, et al.
Publicado: (2018)

Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients
por: Nieuwenhuis, Mireille, et al.
Publicado: (2017)

Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis
por: Vieira, Sandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r3ca4uut51masddfk3psjga40e